| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e18650d78b834c95bac9cdebbac49448 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2016-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24e9ba7e9096d9a661153b356d5f018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de247d44297e32a7d24d91672603bc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d4499417d303d4b716016a3e15efe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b96fd581623466ae1f04ec54393e2a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32597dc112c7ecdbdf0baed44b359618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76b4e7fab38c541ffc9e1ae36122cd7c |
| publicationDate |
2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201718026-A |
| titleOfInvention |
Anti-DLL3 antibody drug combination and method of use |
| abstract |
The present invention provides novel anti-DLL3 antibodies and antibody drug conjugates and methods of treating cancer using such anti-DLL3 antibodies and antibody drug conjugates. |
| priorityDate |
2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |